Subscribe

Bradley Monk, MD, FACOG, FACS

Gynecologic oncologist at Arizona Oncology

Articles by Bradley Monk, MD, FACOG, FACS

Mechanism of VB-111 in Treating Ovarian Cancer: Bradley Monk, MD, FACOG, FACS

ByBradley Monk, MD, FACOG, FACS

June 28th 2021

Bradley Monk, MD, FACOG, FACS, discusses the mechanism of VB-111 in patients with ovarian cancer.

Latest Updated Articles

Trending on CGTlive®

Sarepta Therapeutics’ Limb-Girdle Muscular Dystrophy Gene Therapy SRP-9003 Produces “Robust Expression” of β-SG in Phase 3 Trial

AAVantgarde’s Stargardt Gene Therapy AAVB-039 Garners FDA Orphan Drug Designation, Cleared for Trial in UK

© 2025 MJH Life Sciences^®

All rights reserved.